Hostname: page-component-745bb68f8f-v2bm5 Total loading time: 0 Render date: 2025-02-06T02:58:23.597Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychiatric Uses of Meratran

Published online by Cambridge University Press:  08 February 2018

A. G. Fullerton
A. G. Fullerton*
Affiliation:
Herrison Hospital, Dorchester
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Meratran (alpha-2-piperidyl benzhydrol hydrochloride) is a cerebral stimulant with an action not unlike the amphetamine series but differing in other respects in that it does not interfere with sleep, nor appetite, nor is its use followed by depression. It is not apparently a sympathomimetic drug, since it does not cause any marked cardiovascular pressor effects. Recent reports from America (1) have suggested that the drug is of use in treating patients suffering from depression and psychomotor retardation either due to mental illness, fatigue or a side-effect of other drugs, e.g. chlorpromazine or reserpine.

Type
Original Articles
Information
Journal of Mental Science , Volume 102 , Issue 429 , October 1956 , pp. 801 - 804
Copyright
Copyright © Royal College of Psychiatrists, 1956 

References

1. SCHUT, J. W., and Himwich, H. E., “The effect of Meratran on twenty-five institutionalized mental patients”, Amer. J. Psychiatry, 1955, 111, No. 11.Google Scholar
2. Fabing, H. D., A paper read before a joint meeting of the Texas and Mexican Neuropsychiatric Societies, Galveston, Texas, October, 1955.Google Scholar
3. Forster, M. B., et al., “The clinical effects of (alpha (2 piperidyl) benzhydrol hydrochloride) (Meratran) in states of inactivity in elderly psychiatric patients”, Canad. M.A.J., 1955, 72, 678.Google Scholar
4. Pomeranze, J., “A new antidepressant in geriatrics”, J. Gerontology, 1954, 9, 486.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.